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Plasma vitamin A and E levels in patients with
gastroesophageal cancer in Eastern Anatolia
Ömer YILMAZ1, Hakan DURSUN1, Sait KELEŞ2, Arif YILMAZ1, Nihat OKÇU1

Aim: Gastrointestinal system (GIS) cancers account for a significant percentage of morbidity and mortality worldwide.
Free radicals may play a role in the development of GIS cancers at various stages. The goal of this study was to analyze
the relationship between gastroesophageal cancer and plasma levels of vitamin A and vitamin E, a significant part of
antioxidant defense.
Materials and methods: Twenty-six patients with gastroesophageal cancer diagnosed by endoscopy and histopathologic
examination and 26 healthy volunteer subjects were included in this study. Plasma vitamin A and vitamin E levels were
determined by high-performance liquid chromatography using a commercially available kit.
Results: Plasma vitamin A and vitamin E levels were significantly lower in the gastroesophageal cancer group (1.39 ±
0.137 μmol/L and 13.5 ± 1.29 μmol/L, respectively) than in the control group (2.79 ± 0.163 μmol/L and 21.29 ± 2.58
μmol/L, respectively). The difference was significant at P < 0.001 for vitamin A, and P < 0.05 for vitamin E values.
However, we could not detect any significant difference in plasma vitamin A and vitamin E levels when the stage of the
disease was taken into consideration (P > 0.05).
Conclusion: Decreased plasma vitamin A and vitamin E levels, as important antioxidant components, may be
contributory in the development of gastroesophageal cancer. Diets rich in antioxidant vitamins may be protective against
the development of upper gastrointestinal tract disease.
Key words: Vitamin A, vitamin E, gastroesophageal cancer, oxidative stress

Doğu Anadolu’da gastroözofageal kanserli hastalarda
plazma vitamin A ve E düzeyleri
Amaç: Gastrointestinal sistem (GIS) kanserleri dünya çapında önemli morbidite ve mortalite nedenleridir. Serbest
radikaller farklı evrelerdeki GIS kanserlerinin gelişiminde rol oynayabilirler. Bu çalışmanın amacı antioksidan
savunmanın önemli bir parçası olan vitamin A ve E nin plazma düzeyleriyle gastroözofageal kanserler arasındaki ilişkiyi
analiz etmektir.
Yöntem ve gereç: Çalışmaya endoskopik ve histopatolojik olarak tanı konmuş 26 gastroözofageal kanserli hasta ve 26
sağlıklı gönüllü dahil edildi. Plazma vitamin A ve E düzeyleri high-performance liquid chromatography (HPLC) yöntemi
(HP 1100 kitleri) ile ölçüldü.
Bulgular: Plazma vitamin A ve E düzeyleri gastroözofageal kanserli hastalarda (sırasıyla 1,39 ± 0,137 μmol/L and 13,5
± 1,29 μmol/L) kontrol grubuna (sırasıyla 2,79 ± 0,163 μmol/L and 21,29 ± 2,58 μmol/L) göre belirgin derecede düşük
bulundu. Fark vitamin A için P < 0,001 ve vitamin E için P < 0,05 olarak anlamı tespit edildi. Buna rağmen hastalığın
evresiyle plazma vitamin A ve E düzeyleri arasında ilişki saptanamadı (P > 0,05).

Received: 30.03.2009 – Accepted: 03.08.2009
1
Department of Gastroenterology, Faculty of Medicine, Atatürk University, Erzurum - TURKEY
2
Department of Biochemistry, Faculty of Medicine, Atatürk University, Erzurum - TURKEY
Correspondence: Ömer YILMAZ, Department of Gastroenterology, Faculty of Medicine, Atatürk University, 25070, Erzurum - TURKEY
E-mail: yilmazo@atauni.edu.tr

115

Antioxidant vitamins and gastroesophageal cancer

Sonuç: Önemli antioksidan komponentlerden vitamin A ve E’nin plazma düzeylerindeki azalma, gastroözofageal kanser
gelişmesine katkıda bulunabilir. Antioksidan vitaminlerden zengin besinlerin tüketilmesi, üst gastrointestinal sistem
kanseri gelişmesine karşı koruyucu olabilir.
Anahtar sözcükler: Vitamin A, vitamin E, gastroözofageal kanser, oksidatif stres

Introduction
Under normal circumstances, free radicals are kept
in balance by detoxification via the intracellular and
extracellular antioxidant defense mechanism (1). An
excessive increase in the level of free radicals in the
body and insufficiency in the antioxidant system may
play a significant role in the occurrence of heart
failure, cerebrovascular diseases, and a number of
other diseases, such as cancer (2). Moreover, apart
from inflammation, radiation, and mutagenic
chemicals, an increase in free oxygen radicals may
cause DNA (deoxyribonucleic acid) damage,
mutations, and chromosome aberrations and play a
role in some stages of carcinogenesis (3,4).
Antioxidant vitamins have long been considered to
contribute to reducing the risk of cancers at many
sites. In particular, it has been hypothesized that the
antioxidant activity of vitamins may be protective
against gastrointestinal cancer. Antioxidants inhibit
DNA synthesis, inhibit cell transformation, change
gene expression, decrease cell proliferation, and
protect against oxidative stress (5).
The most constant finding in the relation between
diet and gastrointestinal cancer is the protective effect
of vegetables and fruits. A large number of potentially
anticarcinogenic agents are found in these food
sources, such as vitamin A, vitamin E, and carotenoids
(6).
In this study, we aimed to determine the
relationship between the plasma levels of vitamin A
and vitamin E, which are a significant part of the
antioxidant defense system and have a protective
effect against free radicals in cancer development, and
stomach and esophageal cancer.
Materials and methods
A total of 52 people, comprising 9 with esophagus
adenocarcinoma (5 females, 4 males), 17 with
stomach adenocarcinoma (8 females, 9 males), and 26
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completely healthy individuals, were included in our
study. The mean ages of patients at cancer diagnosis
and of control subjects were 62 years (41-87) and 58
years (31-77), respectively. All of the patients were
examined with imaging methods (ultrasonographycomputerized tomography), and their stage studies
were carried out according to TNM (tumor, lymph
node, metastasis) classification (7). According to this
classification, 17 were in stage III and 9 in stage IV.
Venous blood from all individuals was taken
antecubitally into 5 mL EDTA (ethylene diamine tetra
acetic acid)-containing tubes. Patients were in a
fasting state, and blood was collected in the morning.
The plasma of the collected blood was separated by
centrifuging for 10 min at 2500 rpm at +4 °C. The
separated plasma was immediately stored in
Eppendorf tubes at -80 °C in the dark.
Determination of plasma vitamin A and E levels
Plasma vitamin A and E levels were determined by
high performance liquid chromatography (HPLC)
(HP 1100), using a Chromosystems analytical column
(Chromosystems Instruments and Chemicals GmbH,
Munich, Germany) and mobile phase and other
reagents and standards provided by the same
company (8). The instrument parameters were:
injection volume 50 mL, analytical run time 15-17
min, light-protected sample, flow rate 1.5 mL/min,
and column temperature 20 °C. The UV detector l was
initially set at 325 nm and switched to 295 nm after 3
min.
Statistical analysis
Data were analyzed by the Mann–Whitney U and
Fisher’s exact tests, using SPSS (Statistical Package for
the Social Sciences) 10.0 for Windows (SPSS, Chicago,
IL, USA). In order to assess the correlation between
age of patients with gastroesophageal cancers and
plasma vitamin A and E levels, Pearson’s correlation
analysis was used. The statistically significant
probability level was set at 0.05. The results are given
as mean ± standard deviation (X ± SD).
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Results
Plasma vitamin A levels in 10 of 26 patients were
found to be below normal, while vitamin E levels in 13
patients were below normal. The mean value of
plasma vitamin A in the patient group was 1.39 ±
0.137 μmol/L (control group 2.79 ± 0.163 μmol/L),
and that of plasma vitamin E was 13.5 ± 1.29 μmol/L
(control group 21.29 ± 2.58 μmol/L). In comparison
to the control group, there was a statistically
significant difference in the plasma vitamin A and E
levels of the patient group (P < 0.001 and P < 0.05,
respectively) (Table).
Six of the patients whose plasma vitamin A levels
were below normal levels were stage III and 4 were in
stage IV. Of the patients with normal plasma vitamin
A levels, 11 were stage III and 5 were stage IV. We did
not find any relationship between plasma vitamin A
values and the stage of the patients with
gastroesophageal cancer (P = 0.69) (Figure 1).

Ten of the patients whose plasma vitamin E levels
were below normal were in stage III and 3 were in
stage IV. Of the patients with normal plasma vitamin
E levels, 7 were in stage III and 6 were in stage IV. We
did not determine any relationship between plasma
vitamin E values and the stage of the patients with
gastroesophageal cancer (P = 0.41) (Figure 2).
Discussion
Under oxidative stress, excessive production of
free oxygen radicals or disability in antioxidant
systems may occur. The fact that oxidative stress has
a significant role in cancer development has been
shown in several published studies (3,9). Nutritional
factors are thought to be paramount, with N-nitroso
and other dietary compounds acting as carcinogens,
while antioxidants and other protective substances in
foods inhibit the carcinogenic process (6).

Table. Vitamin A and E levels (mean ± SD) in patient and control groups.

Cases (n)
Age (year)
Vitamin A (μmol/L)
Vitamin E (μmol/L)

Control group

Gastroesophageal cancer

26
58 ± 9.36
2.79 ± 0.163
21.29 ± 2.58

26
62.1 ± 10.67
1.39 ± 0.137
13.5 ± 1.29

3.5

P < 0.001
P < 0.05

30

3.0
2.5
2.0

Vitamin E

Vitamin A

20

1.5

10

1.0
0.5
0.0
N=

17
3

9
4

Stage

Figure 1. Relationship between plasma vitamin A levels and stage
of gastroesophageal cancer (P > 0.05).

0
N=

17
3

9
4

Stage

Figure 2. Relationship between plasma vitamin E levels and stage
of gastroesophageal cancer (P > 0.05).
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Vitamin A is also a well-known antioxidant, but its
protective effect against gastric cancer has rarely been
reported (10). Vitamin E has some known or
presumed functions in addition to being an
antioxidant that may have a part in inhibiting
carcinogenesis. Results of chemical carcinogenesis
studies in rodents suggest that vitamin E inhibits the
development of cancer at many sites, and the results of
prospective cohort studies and randomized
intervention trials in humans have also provided some
evidence that vitamin E plays a role in the prevention
of gastroesophageal cancers (11). Zhang (12)
described the beneficial effects of vitamin E in relation
to adenocarcinoma development. Thus, the serum
levels of these antioxidant vitamins are considered to
reflect the antioxidant status of the body involved in
the process of carcinogenesis (13).
In China, 29,584 participants were sampled from
the general population of Linxian. This trial tested 4
different combinations of nutrient supplements for
5.25 years. The group supplemented with selenium,
ß-carotene, and vitamin E had a statistically
significant reduction of 13% in cancer mortality (5).
In another study carried out in the same country, the
levels of vitamin C and serum β-carotene in
individuals with intestinal metaplasia, which is a
gastric precancerous lesion, were significantly lower
than in individuals with normal gastric mucosa (14).
One study from Sweden evaluated the association
between the intake of antioxidants (vitamin E and βcarotene) and esophageal cancers, and reported that
these nutrients are inversely associated with the risk of
carcinoma of the esophagus (15).
In Italy, in a study of 382 patients with stomach
cancer, the intake of high-doses of a-tocopherol was
found to prolong life expectancy. In contrast to other
reports in the literature, that study was unable to
determine the effectiveness of other antioxidants (16).
Stahelin et al. (17) examined antioxidant vitamin
values in 2974 individuals. During his 12-year followup, 204 of them died from cancer. In those who died,
especially those who died of stomach cancer, plasma
carotene levels were found to be low (P < 0.01).
Knekt et al. (18) measured the levels of serum atocopherol in 36,265 people and followed them for 8

118

years to determine who developed cancer. A reverse
correlation between serum vitamin E levels and
cancer development was found, which was
particularly striking in gastrointestinal cancers. The
incidence of cancer was 1.5 times greater in those
whose serum a-tocopherol levels were low, supporting
the hypothesis that dietary intake of vitamin E is
protective against cancers.
Tsubono et al. (19) examined 634 individuals from
5 different Japanese populations in which mortality
rates from stomach cancer varied, and found that the
levels of plasma b-carotene and a-tocopherol are
inversely related to the incidence of stomach cancers.
In our study of vitamin A and E levels, the
distinction between the patient and control groups is
statistically significant. While there is a significant
difference between healthy controls and patients with
gastroesophageal cancers in terms of plasma vitamin
A and E levels, no significant difference was
determined in vitamin A and E levels between cancer
patients according to cancer stage III or IV.
Our results, indicating low plasma vitamin A and
E levels in patients with stomach and esophageal
cancers, support the possibility that the lack of
antioxidant vitamins is a significant etiologic factor.
But is the vitamin deficiency in these patients a cause
or a result? The poor nutritional status of cancer
patients is a known fact. Thus, as the stage of the
disease progresses, we could expect that any
deficiency in antioxidant vitamins would increase.
Nevertheless, in our study we were unable to
determine any significant difference in plasma
vitamin A and E levels between patients with cancer
stage III or IV. This would suggest that the deficient
levels of plasma vitamin A and E in our patients were
a cause.
In summary, our results confirm the important
role that diet plays in the etiology of gastroesophageal
cancer. Diets rich in vegetables, fruits, vitamins, and
antioxidants may be a protective factor against
stomach and esophageal cancers. Further studies are
necessary to clarify whether additional vitamin
supplementation can reduce the risk of
gastroesophageal cancers.
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